We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Gonzalgo MD, PhD

Mark L Gonzalgo MD, PhD

Professor of Urology; Associate Director for Clinical Affairs, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida

Dr. Mark Gonzalgo is professor of urology and associate director for clinical affairs at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine. Dr. Gonzalgo is a urologic oncologist with expertise in open and robotic surgical approaches for the treatment of prostate, bladder, and kidney cancers. He received his undergraduate degree with honors from the University of California at Berkeley and completed medical and graduate school at the USC Keck School of Medicine. Dr. Gonzalgo completed his general surgery and urology training at Johns Hopkins and a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center. Dr. Gonzalgo is a recognized expert in DNA methylation and is particularly interested in developing new diagnostic and therapeutic approaches for cancer detection and treatment.  He has carried out pioneering research on the molecular biology and early detection of prostate, bladder, and kidney cancer and has published extensively on the scientific and clinical aspects of these diseases. Dr. Gonzalgo has been recognized as a Top Doctor by US News & World Report and is a member of the scientific advisory board of the Bladder Cancer Advocacy Network (BCAN).